dualyx
Technologiepark-Zwijnaarde 94
9052 Gent
BE
dualyx
Foundation date
21/11/2019
Sector
#Biotechnology - TherapeuticsSubsector
- #Therapeutics - Proteins
- #Other - Industrial Biotechnology
- #Other - Veterinary
- #Pharma - Cell therapy
- #Pharma - Gene therapy
- #Professional Services - IT services
Therapeutic areas
- #Diseases of the blood and blood-forming organs - immune disorders
- #Musculoskeletal system and connective tissue
- #Respiratory system
- #Skin and subcutaneous tissue
dualyx NV focuses on the discovery and development of highly innovative biologicals for the treatment of autoimmune and rare diseases. We aim to create long-lasting treatments for patients with a high unmet medical need.
Upcoming events
All events-
1212 '23
BioFIT 2023
Event by: Eurasanté -
0602 '24
Discovery to Innovation in Animal Health - 2024
Event by: Ghent University, Provaxs, Paul Dick & Associates -
0712 '23
The GxP Academy: Cleaning Validatie
Event by: Advipro
Latest news
More news-
Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China
1 day ago
Read more
-
Celyad announces management change
Friday December 1st 2023
Read more
-
Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States
Thursday November 30th 2023
Read more
Jobs
More jobs-
03/12/23
Limburg
PhD position in the field of neuroimmunology, mouse modelling and induced pluripotent stem cells
Permanent
VIB -
-
01/12/23
Antwerp, Brussels, East Flanders, Hainaut, Liège, Limburg, Luxembourg, Namur, Flemish Brabant, Walloon Brabant, West Flanders
Sales Engineer Belgium
Permanent
Thema Group Belgium
More info?
Ellen Telleir
Communication Coordinator